Jennifer Miller, PhD
Jennifer supports the team in investment sourcing and technical due diligence, with a particular focus on AI/ML and computational drug discovery. She also serves as an advisor and board member for portfolio companies. In addition to SymBiosis, Jennifer serves as an advisor and fractional executive for startup companies working at the intersection of life science and technology. Previously, Jennifer led Strategy and Corporate Development for Depomed and served in the Corporate Development and Technology group at Amphora Discovery. She began her career as a scientist and held R&D leadership roles of increasing responsibility at Signature Bioscience, DuPont Pharma Research Labs and CombiChem. She has served as a “Big Data in Health” NIH SBIR grant program reviewer and as a member of MyoKardia’s Digital Health Steering Committee. Jennifer earned a PhD in Pharmaceutical Chemistry from UCSF and a BS in Computer Science from San Diego State University.